Literature DB >> 10680019

A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax.

S Kagawa1, S A Pearson, L Ji, K Xu, T J McDonnell, S G Swisher, J A Roth, B Fang.   

Abstract

The bax gene plays a critical role in signaling apoptosis and expression through gene transfer may be valuable in the treatment of a variety of apoptosis-related diseases such as cancer. However, constructing an adenoviral vector expressing a bax gene driven by a constitutive promoter has been difficult, presumably because of the gene's high proapoptotic activity. Here we report a system that induces the expression of the bax gene safely by adenovirus-mediated gene cotransfer. Briefly, the system involves an adenoviral vector containing a human bax cDNA driven by a synthetic promoter consisting of five GAL4-binding sites and a TATA box (GT). This vector expresses a minimal background level of bax protein in cultured mammalian cells thus preventing apoptosis of packaging cells, however, expression of the bax gene can be induced substantially in vitro and in vivo by transferring it into target cells along with an adenoviral vector expressing the transactivator, fusion protein GAL4/VP16. Extensive apoptosis was observed after induction of the bax gene both in cultured human lung carcinoma cells and in the livers of Balb/c mice. Our results suggest that this GAL4 gene regulatory system provides an alternative approach to constructing viral vectors that express potentially toxic genes. Gene Therapy (2000) 7, 75-79.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680019     DOI: 10.1038/sj.gt.3301048

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  13 in total

Review 1.  Gene therapy in lung cancer.

Authors:  S G Swisher; J A Roth
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

Review 2.  Mitochondria: a target for cancer therapy.

Authors:  Jeffrey S Armstrong
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 3.  Mitochondrial medicine: pharmacological targeting of mitochondria in disease.

Authors:  J S Armstrong
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

4.  Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase.

Authors:  Hui Yan; Brook Brouha; Tong Liu; Deepak Raj; Diana Biddle; Ray Lee; Douglas Grossman
Journal:  J Dermatol Sci       Date:  2006-06-27       Impact factor: 4.563

5.  A rapid and efficient method for purification of recombinant adenovirus with arginine-glycine-aspartic acid-modified fibers.

Authors:  Henry H Peng; Shuhong Wu; John J Davis; Li Wang; Jack A Roth; Frank C Marini; Bingliang Fang
Journal:  Anal Biochem       Date:  2006-05-03       Impact factor: 3.365

6.  Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29.

Authors:  Xiang-Ming Xu; Chao He; Xiao-Tong Hu; Bing-Liang Fang
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

7.  Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer.

Authors:  Y Tsunemitsu; S Kagawa; N Tokunaga; S Otani; T Umeoka; J A Roth; B Fang; N Tanaka; T Fujiwara
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 8.  Targeting the Bcl-2 family for cancer therapy.

Authors:  Shibu Thomas; Bridget A Quinn; Swadesh K Das; Rupesh Dash; Luni Emdad; Santanu Dasgupta; Xiang-Yang Wang; Paul Dent; John C Reed; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Ther Targets       Date:  2012-11-22       Impact factor: 6.902

9.  Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells.

Authors:  Simin Sharifi; Jaleh Barar; Mohammad Saeid Hejazi; Nasser Samadi
Journal:  Adv Pharm Bull       Date:  2015-09-19

10.  Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.

Authors:  Christopher P Baines; Robert A Kaiser; Tatiana Sheiko; William J Craigen; Jeffery D Molkentin
Journal:  Nat Cell Biol       Date:  2007-04-08       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.